Browse drugs

…l 2019, whereas no CDS strains were isolated from 2020 to 2023. Spectinomycin was active against all isolates. Serotyping results revealed a …

…e in bipolar disorder, but the available treatments are scarce. Lithium is a first-line option in several guidelines despite limited ev…

…vels and low C5 activity, confirming transplacental transfer of ravulizumab. The infant, now 4 months old, remains well.Conclusions This is…

…. These findings suggest that single-injection SPIP blocks with liposomal bupivacaine may not be as effective as repeated injections or catheters in …

… including alirocumab, bococizumab, evolocumab, tafolecimab and inclisiran. Eligible studies reported changes in LDL-C, apolipoprotein B (…

…Objectives Pevonedistat is a new cytotoxic used in association with azacitidine for the…

…field and adequate OCT strength were included in this analysis. IMOvifa had significantly shorter testing time (3.7 vs 5.3 mins), lower…

…ged. Reductions in TB and DB were observed after treatment with maralixibat. No clinically meaningful changes in ALT or AST were observed w…

… skin involvement. Only one patient required discontinuation of infliximab.Our findings suggest that paediatric IBD patients can develop a…

…tment with phenobarbitone when standard therapies fail. Current phenobarbitone dosing guidelines, however, lack a robust evidence base.Methods…

…revious phase Ib-II trial, we evaluated a sequential regimen of gemcitabine plus nab-paclitaxel (GEMBRAX) followed by FOLFIRINOX (FFX), whi…

…C 8 x 10^9/L.Management Antibiotics: IV vancomycin, gentamicin, rifampicin.Blood pressure control: Labetalol infusion to maintain SBP 100–…